Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yamazaki

Showing results (81-90 of 252) with videos related to

Pageof 26
Sort By:
International Journal of Clinical Oncology|May 25, 2025
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumorsKei Muro, Kentaro Yamazaki, Shigenori Kadowaki, et al.
American Journal of Veterinary Research|February 25, 2021
Evaluation of cerebral blood flow in the hippocampus, thalamus, and basal ganglia and the volume of the hippocampus in dogs before and during treatment with prednisoloneKentaro Yamazaki, Aritada Yoshimura, Shunsuke Miyahara, et al.
Acta Dermato-Venereologica|May 16, 2025
Inhibitory Effect of 505 nm Green Light Emitting Diode on Melanin Synthesis in Cellular Experiments and a Human Intervention StudyYoshihito Mima, Takehiro Yamada, Jun Omatsu, et al.
International Journal of Clinical Oncology|December 8, 2009
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patientsAkihiro Tamiya, Kentaro Yamazaki, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|October 11, 2008
Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancerNozomu Machida, Takayuki Yoshino, Narikazu Boku, et al.
Annals of Surgical Oncology|April 4, 2022
The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous InvasionHidemasa Kubo, Katsuhisa Ohgi, Teiichi Sugiura, et al.
Cancer Science|March 25, 2015
Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patientsHiroya Taniguchi, Kentaro Yamazaki, Takayuki Yoshino, et al.
Clinical Journal of Gastroenterology|July 25, 2023
Discordant microsatellite instability findings in two samples from a patient with biliary cancer that responded to pembrolizumabHiroyuki Matsubayashi, Akiko Todaka, Hirotoshi Ishiwatari, et al.
Biochemical and Biophysical Research Communications|March 1, 2011
Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutationMika Kato Kaneko, Wei Tian, Shingo Takano, et al.
International Journal of Clinical Oncology|October 25, 2011
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancerTakahiro Tsushima, Shuichi Hironaka, Narikazu Boku, et al.
Pageof 26

Showing results (81-90 of 252) with videos related to

Sort By:
Pageof 26
International Journal of Clinical Oncology|May 25, 2025
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumorsKei Muro, Kentaro Yamazaki, Shigenori Kadowaki, et al.
American Journal of Veterinary Research|February 25, 2021
Evaluation of cerebral blood flow in the hippocampus, thalamus, and basal ganglia and the volume of the hippocampus in dogs before and during treatment with prednisoloneKentaro Yamazaki, Aritada Yoshimura, Shunsuke Miyahara, et al.
Acta Dermato-Venereologica|May 16, 2025
Inhibitory Effect of 505 nm Green Light Emitting Diode on Melanin Synthesis in Cellular Experiments and a Human Intervention StudyYoshihito Mima, Takehiro Yamada, Jun Omatsu, et al.
International Journal of Clinical Oncology|December 8, 2009
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patientsAkihiro Tamiya, Kentaro Yamazaki, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|October 11, 2008
Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancerNozomu Machida, Takayuki Yoshino, Narikazu Boku, et al.
Annals of Surgical Oncology|April 4, 2022
The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous InvasionHidemasa Kubo, Katsuhisa Ohgi, Teiichi Sugiura, et al.
Cancer Science|March 25, 2015
Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patientsHiroya Taniguchi, Kentaro Yamazaki, Takayuki Yoshino, et al.
Clinical Journal of Gastroenterology|July 25, 2023
Discordant microsatellite instability findings in two samples from a patient with biliary cancer that responded to pembrolizumabHiroyuki Matsubayashi, Akiko Todaka, Hirotoshi Ishiwatari, et al.
Biochemical and Biophysical Research Communications|March 1, 2011
Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutationMika Kato Kaneko, Wei Tian, Shingo Takano, et al.
International Journal of Clinical Oncology|October 25, 2011
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancerTakahiro Tsushima, Shuichi Hironaka, Narikazu Boku, et al.
Pageof 26